# OnCo record safusidenib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/safusidenib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "safusidenib" ;
  schema:name "Safusidenib"@en ;
  schema:alternateName "DS-1001b"@en ;
  schema:description "Safusidenib is an experimental small molecule inhibitor from Nuvation Bio in phase 3 trials for glioma & glioblastoma, aimed at IDH1 / IDH2."@en ;
  schema:url <https://onco.cc/drugs/safusidenib/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=AB-218>, <https://www.nuvationbio.com/pipeline> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "small molecule inhibitor" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/>, <https://onco.cc/cancers/idh-mutant-astrocytoma/>, <https://onco.cc/cancers/oligodendroglioma/> ;
  onco:targets <https://onco.cc/targets/idh/> ;
  onco:companies <https://onco.cc/companies/nuvation-bio/> ;
  onco:trials <https://onco.cc/trials/nct05303519/>, <https://onco.cc/trials/nct04458272/> .